Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

September 28, 2023 updated by: Northwell Health
Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.

Study Overview

Status

Recruiting

Detailed Description

In Phase 1 of the project, we will confirm a model predicting factors associated with later disengagement from CSC treatment. In Phase 2, we will compare disengagement among high-risk individuals with a CSC Step-down intervention to that with standard CSC care. The Step-down intervention will use web-based telemedicine and a smartphone app, to decrease disengagement likelihood. High-risk participants identified by predictors found in Phase 1 will be offered the intervention.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Cristina Gonzalez, MS
  • Phone Number: 347-804-3605

Study Locations

    • Florida
      • Lauderdale Lakes, Florida, United States, 33319
        • Recruiting
        • Henderson Behavioral Health
        • Contact:
          • Suzelle Guinart
    • Michigan
      • Grand Rapids, Michigan, United States, 49503
        • Recruiting
        • InterAct of Michigan
        • Contact:
          • Jacob Gonzales
      • Kalamazoo, Michigan, United States, 49007
        • Recruiting
        • InterAct of Michigan
        • Contact:
          • Dana Schraber

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Enrolled into a CSC program

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: CSC Step-down intervention
Web-based telemedicine and a smartphone app, to decrease disengagement likelihood
Web-based telemedicine and a smartphone app, to decrease disengagement likelihood
Other: Usual Care
Usual care provided by CSC center
Usual Care provided by CSC center

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disengagement rate
Time Frame: Minimum of 6 months
Rate of disengagement from CSC program
Minimum of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Estimated)

April 15, 2024

Study Completion (Estimated)

May 30, 2024

Study Registration Dates

First Submitted

July 1, 2019

First Submitted That Met QC Criteria

July 1, 2019

First Posted (Actual)

July 2, 2019

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 19-0307 -B

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on First Episode Psychosis

Clinical Trials on CSC Step-down intervention

3
Subscribe